SEC filing · 8-K

Alaunos Therapeutics, Inc.: Material agreement

Alaunos Therapeutics raised approximately $915,400.50 in net proceeds through a registered direct offering.

Filed September 22, 2026

Neutral news

What happened

On September 18, 2026, Alaunos Therapeutics agreed to sell 380,469 common shares at $1.46 per share and 386,654 pre-funded warrants at $1.459 per warrant.

The full interpretation is in the app

Why it matters, the key numbers from the document and what to watch next: the full interpretation of every report is part of Pro.

Read the full interpretation

Read the original

Filing document on SEC.gov Press release (EX-99.1) All documents of this filing

Back to Alaunos Therapeutics, Inc.

Summary generated automatically from the filing text and checked against it: every number above is printed in the document. It describes the filing and is not investment advice. Read the original before relying on it.